|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rustgi AK and El-Serag HB: Esophageal
carcinoma. N Engl J Med. 371:2499–2509. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics for Hispanics/Latinos, 2012. CA Cancer J Clin.
62:283–298. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Deng HY, Alai G, Luo J, Li G, Zhuo ZG and
Lin YD: Cancerous esophageal stenosis before treatment was
significantly correlated to poor prognosis of patients with
esophageal cancer: A meta-analysis. J Thorac Dis. 10:4212–4219.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu J, Chen Q, Liu P, Jia W, Chen Z and Xu
Z: Integration of mRNA and miRNA analysis reveals the molecular
mechanism underlying salt and alkali stress Tolerance in tobacco.
Int J Mol Sci. 20:E23912019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ye Y, Li SL and Wang SY: Construction and
analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal
the key genes associated with prostate cancer. PLoS One.
13:e01980552018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Y, Liang Y and Lu Q: MicroRNA
epigenetic alterations: Predicting biomarkers and therapeutic
targets in human diseases. Clin Genet. 74:307–315. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Feber A, Xi L, Luketich JD, Pennathur A,
Landreneau RJ, Wu M, Swanson SJ, Godfrey TE and Litle VR: MicroRNA
expression profiles of esophageal cancer. J Thorac Cardiovasc Surg.
135:255–260; discussion 260. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yuan L, Yuan P, Yuan H, Wang Z, Run Z,
Chen G, Zhao P and Xu B: miR-542-3p inhibits colorectal cancer cell
proliferation, migration and invasion by targeting OTUB1. Am J
Cancer Res. 7:159–172. 2017.PubMed/NCBI
|
|
14
|
Althoff K, Lindner S, Odersky A, Mestdagh
P, Beckers A, Karczewski S, Molenaar JJ, Bohrer A, Knauer S,
Speleman F, et al: miR-542-3p exerts tumor suppressive functions in
neuroblastoma by downregulating Survivin. Int J Cancer.
136:1308–1320. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Karunarathna U, Kongsema M, Zona S, Gong
C, Cabrera E, Gomes AR, Man EP, Khongkow P, Tsang JW, Khoo US, et
al: OTUB1 inhibits the ubiquitination and degradation of FOXM1 in
breast cancer and epirubicin resistance. Oncogene. 35:1433–1444.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Baietti MF, Simicek M, Abbasi Asbagh L,
Radaelli E, Lievens S, Crowther J, Steklov M, Aushev VN, Martínez
García D, Tavernier J and Sablina AA: OTUB1 triggers lung cancer
development by inhibiting RAS monoubiquitination. EMBO Mol Med.
8:288–303. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y, Zhou X, Xu M, Weng W, Zhang Q,
Yang Y, Wei P and Du X: OTUB1-catalyzed deubiquitination of FOXM1
facilitates tumor progression and predicts a poor prognosis in
ovarian cancer. Oncotarget. 7:36681–36697. 2016.PubMed/NCBI
|
|
18
|
Zhou H, Liu Y, Zhu R, Ding F, Cao X, Lin D
and Liu Z: OTUB1 promotes esophageal squamous cell carcinoma
metastasis through modulating Snail stability. Oncogene.
37:3356–3368. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Agarwal V, Bell GW, Nam J and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. Aug 4–2015.(Epub ahead of print). doi: 10.7554/eLife.05005.
View Article : Google Scholar
|
|
21
|
Lee K and Ferguson LR: MicroRNA biomarkers
predicting risk, initiation and progression of colorectal cancer.
World J Gastroenterol. 22:7389–7401. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Paliouras AR, Monteverde T and Garofalo M:
Oncogene-induced regulation of microRNA expression: Implications
for cancer initiation, progression and therapy. Cancer Lett.
421:152–160. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fang Y, Fang D and Hu J: MicroRNA and its
roles in esophageal cancer. Med Sci Monit. 18:RA22–RA30. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li X, Wainscott C and Xi Y: MicroRNA
provides insight into understanding esophageal cancer. Thorac
Cancer. 2:134–142. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qi B, Liu SG, Qin XG, Yao WJ, Lu JG, Guo
L, Wang TY, Li HC and Zhao BS: Overregulation of microRNA-212 in
the poor prognosis of esophageal cancer patients. Genet Mol Res.
13:7800–7807. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu W, Dang S, Feng Q, Liang J, Wang Y and
Fan N: MicroRNA-542-3p inhibits the growth of hepatocellular
carcinoma cells by targeting FZD7/Wnt signaling pathway. Biochem
Biophys Res Commun. 482:100–105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu Y, You J, Li F, Wang F and Wang Y:
MicroRNA-542-3p suppresses tumor cell proliferation via targeting
Smad2 inhuman osteosarcoma. Oncol Lett. 15:6895–6902.
2018.PubMed/NCBI
|
|
28
|
Rang Z, Yang G, Wang YW and Cui F:
miR-542-3p suppresses invasion and metastasis by targeting the
proto-oncogene serine/threonine protein kinase, PIM1, in melanoma.
Biochem Biophys Res Commun. 474:315–320. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wiener R, DiBello AT, Lombardi PM, Guzzo
CM, Zhang X, Matunis MJ and Wolberger C: E2 ubiquitin-conjugating
enzymes regulate the deubiquitinating activity of OTUB1. Nat Struct
Mol Biol. 20:1033–1039. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun XX, Challagundla KB and Dai MS:
Positive regulation of p53 stability and activity by the
deubiquitinating enzyme Otubain 1. EMBO J. 31:576–592. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stanisić V, Malovannaya A, Qin J, Lonard
DM and O'Malley BW: OTU Domain-containing ubiquitin
aldehyde-binding protein 1 (OTUB1) deubiquitinates estrogen
receptor (ER) alpha and affects ERalpha transcriptional activity. J
Biol Chem. 284:16135–16145. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mansoori B, Sandoghchian Shotorbani S and
Baradaran B: RNA interference and its role in cancer therapy. Adv
Pharm Bull. 4:313–321. 2014.PubMed/NCBI
|
|
34
|
Hemmatzadeh M, Mohammadi H, Babaie F,
Yousefi M, Ebrazeh M, Mansoori B, Shanehbandi D and Baradaran B:
Snail-1 silencing by siRNA inhibits migration of TE-8 esophageal
cancer cells through downregulation of metastasis-related genes.
Adv Pharm Bull. 8:437–445. 2018. View Article : Google Scholar : PubMed/NCBI
|
